dextroamphetamine has been researched along with lisdexamfetamine dimesylate in 174 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 33 (18.97) | 29.6817 |
| 2010's | 126 (72.41) | 24.3611 |
| 2020's | 15 (8.62) | 2.80 |
| Authors | Studies |
|---|---|
| Krishnan, S; Moncrief, S | 1 |
| Blick, SK; Keating, GM | 1 |
| Easley, C; Elia, J; Kirkpatrick, P | 1 |
| Biederman, J; Findling, RL; Krishnan, S; McGough, JJ; Zhang, Y | 1 |
| Biederman, J; Boellner, SW; Childress, A; Krishnan, S; Lopez, FA; Zhang, Y | 1 |
| Krishnan, S; Montcrief, S | 1 |
| Krishnan, SM; Stark, JG | 1 |
| Faraone, SV; Upadhyaya, HP | 1 |
| Krishnan, S; Zhang, Y | 1 |
| Manos, MJ | 1 |
| Faraone, SV | 2 |
| Madaan, V | 1 |
| Aleguas, A; Anderson, DL; Griffith, JR; Spiller, HA; Weber, JA | 1 |
| Childress, AC; Findling, RL; Krishnan, S; McGough, JJ | 1 |
| Jasinski, DR; Krishnan, S | 2 |
| Howland, RH | 2 |
| Arnold, V; Ginsberg, LD; Lopez, FA | 1 |
| Krishnan, SM; Pennick, M; Stark, JG | 1 |
| Adler, LA; Biederman, J; Goodman, DW; Kollins, SH; Krishnan, S; Weisler, RH; Zhang, Y | 1 |
| Najib, J | 1 |
| Cowles, BJ | 1 |
| Siddiqui, MA; Weber, J | 1 |
| Carter, LP; Haddox, JD; Henningfield, JE; Johnson, RE; Lindholm, A; McCormick, CG; Rosen, S; Seeger, V; Varughese, S; Waxman, D; Wissel, J | 1 |
| Rostain, AL | 1 |
| Buckwalter, M; Ermer, JC; Haffey, MB; Homolka, R; Lasseter, KC; Martin, P; Zhang, P | 1 |
| Jun, A | 1 |
| Bhattacharya, P; Popovic, B; Sivaswamy, L | 1 |
| Kratochvil, CJ; May, DE | 1 |
| Findling, RL; Gao, J; Ginsberg, LD; Jain, R | 1 |
| Adler, L; Gao, J; Mattingly, G; Squires, L; Weisler, R; Young, J | 1 |
| Adler, LA; Goodman, DW; Hamdani, M; Niebler, GE; Weisler, RH | 1 |
| Buckwalter, M; Ermer, J; Homolka, R; Martin, P; Purkayastha, J; Roesch, B | 1 |
| Boellner, SW; Krishnan, S; Stark, JG; Zhang, Y | 1 |
| Faraone, SV; Glatt, SJ; Kollins, SH; Spencer, TJ | 1 |
| Antonucci, D; Kerney, DL; Kunins, C; López, FA; Manos, M | 1 |
| Mattingly, G | 1 |
| Hood, B; Nowicki, MJ | 1 |
| Brams, M; López, FA; Moon, E; Pucci, M | 1 |
| Giblin, JM; Strobel, AL | 1 |
| Brams, M; Gao, J; Gasior, M; Giblin, J; Squires, L; Wigal, T | 1 |
| Roman, MW | 1 |
| Brams, M; Brown, TE; Childress, A; Gao, J; Gasior, M | 1 |
| Jun, A; Lerner, MA; Stehli, A; Steinberg-Epstein, R; Wigal, SB; Wong, AA | 2 |
| Crinella, F; Lakes, K; Maltas, S; Schuck, S; Stehli, A; Steinhoff, K; Wigal, SB | 1 |
| Dew, RE; Kollins, SH | 1 |
| Adeyi, B; Babcock, T; Dirks, B; Findling, RL; Ginsberg, L; Jain, R; Katic, A; Lasser, R; Richards, C; Scheckner, B; Turgay, A | 1 |
| Chae, S; Patel, A; Steinberg-Epstein, R; Wigal, SB | 1 |
| Adeyi, B; Babcock, T; Dirks, B; Findling, RL; Gao, J; Ginsberg, L; Jain, R; Lasser, R; Richards, C; Sarkis, E; Scheckner, B; Turgay, A | 1 |
| Faraone, SV; Glatt, SJ; Waschbusch, DA; Waxmonsky, JG | 1 |
| Childress, AC; Cutler, AJ; Ferreira-Cornwell, MC; Findling, RL; Gasior, M; Hamdani, M; Squires, L | 1 |
| Adeyi, B; Adler, LA; Babcock, T; Dirks, B; Ginsberg, L; Katic, A; Lasser, R; Scheckner, B | 1 |
| Brams, M; Gao, J; Gasior, M; Giblin, J; Wigal, T | 2 |
| Donovan, SJ; Levin, FR | 1 |
| Faraone, SV; Glatt, SJ; Goodman, D; Kollins, SH; Spencer, TJ | 1 |
| Buckwalter, M; Dennis, K; Diehl, B; Doll, WJ; Ermer, JC; Haffey, MB; Martin, PT; Page, RC; Sandefer, EP | 1 |
| Franke, AG; Huss, M; Konrad, A; Lieb, K | 1 |
| Roth, T; Surman, CB | 1 |
| Adeyi, B; Babcock, T; Brams, M; Brown, TE; Dirks, B; Gasior, M; Scheckner, B; Wigal, T | 1 |
| Corcoran, M; Dennis, K; Doll, WJ; Ermer, JC; Haffey, MB; Martin, P; Page, RC; Sandefer, EP; Trespidi, L | 1 |
| Carson, KM; Dupaul, GJ; O'Dell, SM; Rossi, JS; Swentosky, A; Verdi, G; Vilardo, BA; Weyandt, LL | 1 |
| Adeyi, B; Babcock, T; Dirks, B; Findling, RL; Greenbaum, M; McGough, JJ; Scheckner, B | 1 |
| Childress, AC; Sallee, FR | 1 |
| Biederman, J; Bourgeois, M; Faraone, SV; Fried, R; Godfrey, KM; Hammerness, P; Mehler, B; Meller, B; Miller, C; Petty, CR; Reimer, B; Surman, C | 1 |
| Bosch, R; Casas, M; Chalita, PJ; Palomar, G; Prats, L; Ramos-Quiroga, JA; Vidal, R | 1 |
| Chrisman, AK; Dew, R; English, JS; Itchon-Ramos, N; Kollins, SH; McClernon, FJ; O'Brien, B | 1 |
| Betts, KA; Erder, MH; Hodgkins, P; Parikh, K; Setyawan, J; Signorovitch, JE; Wu, EQ; Xie, J; Yang, H | 1 |
| Baggish, A; Hammerness, P; Schillinger, M; Shelley-Abrahamson, R; Surman, C; Systrom, D; Wilens, TE; Zusman, R | 1 |
| Adeyi, B; Arnold, V; Babcock, T; Childress, AC; Dirks, B; Lasser, R; Lopez, FA; Scheckner, B | 1 |
| Froelich, J; Johnson, M; Shaw, M; Soutullo, CA; Steer, C | 1 |
| Brams, M; Ferreira-Cornwell, MC; Findling, RL; Gasior, M; Hamdani, M; Squires, L; Weisler, R | 1 |
| Brammer, R; Gosden, J; Hackett, D; Heal, DJ; Kulkarni, R; Rowley, HL | 1 |
| Banaschewski, T; Döpfner, M; Frölich, J; Lehmkuhl, G; Spanagel, R | 1 |
| Benedict, RH; Cookfair, D; Morrow, SA; Patrick, K; Smerbeck, A; Weinstock-Guttman, B | 1 |
| Harris, NS; Pitman, JT | 1 |
| Young, JL | 2 |
| Schaeffer, T | 1 |
| Akingbola, OA; Singh, D | 1 |
| Baer, L; Biederman, J; Bourgeois, M; Faraone, SV; Fried, R; Godfrey, KM; Hammerness, P; Mehler, B; Meller, B; Miller, C; Petty, CR; Reimer, B; Surman, C | 1 |
| Gratton, E; Polzonetti, CM; Stehli, A; Wigal, SB | 1 |
| Raja, P; Shukla, A; Wigal, SB | 1 |
| Adeyi, B; Babcock, T; Dirks, B; Scheckner, B | 1 |
| Banaschewski, T; Buitelaar, J; Coghill, D; Cortese, S; Danckaerts, M; Dittmann, RW; Graham, J; Holtmann, M; Sergeant, J; Taylor, E | 1 |
| Anderson, C; Banaschewski, T; Civil, R; Coghill, D; Higgins, N; Johnson, M; Lecendreux, M; Lyne, A; Soutullo, C; Squires, L; Zuddas, A | 1 |
| Araújo, MM; Carvalho, AF; Cordeiro, RC; de Lucena, DF; Hyphantis, TN; Macêdo, DS; McIntyre, RS; Queiroz, AI; Quevedo, J; Sousa, FC; Vasconcelos, SM | 1 |
| Adeyi, B; Babcock, T; Dirks, B; Goodman, DW; Lasser, R; Mattingly, GW; Scheckner, B; Weisler, RH; Young, J | 1 |
| Adeyi, B; Arnold, V; Babcock, T; Childress, A; Dirks, B; Lasser, RA; López, FA; Scheckner, B; Shepski, J | 1 |
| Childress, AC; Cutler, AJ; Ferreira-Cornwell, MC; Findling, RL; Gasior, M; Hamdani, M; Saylor, K | 2 |
| Adeyi, B; Babcock, T; DeLeon, A; Dirks, B; Findling, RL; Ginsberg, LD; Lasser, R; Scheckner, B | 1 |
| Connor, DF; Faraone, SV; Jensen, PS; Miesle, LM; Rostain, A | 1 |
| Corcoran, M; Ermer, J; Haffey, MB; Harlin, B; Lasseter, K; Martin, P; Purkayastha, J; Richards, C; Roesch, B | 1 |
| Gosden, J; Heal, DJ; Nutt, DJ; Smith, SL | 1 |
| Leroux, JR; López, FA | 1 |
| Corcoran, ME; Ermer, J; Fetterolf, J; Haffey, M; Martin, P; Preston, P; Purkayastha, J; Roesch, B; Wang, P | 1 |
| Cloutier, M; Erder, MH; Gauthier, G; Guérin, A; Hodgkins, P; Setyawan, J; Wu, EQ | 1 |
| Adeyi, B; Babcock, T; Burtea, T; Dirks, B; Duncan, D; Jain, R; Lasser, R; Renna, J; Scheckner, B | 1 |
| Banaschewski, T; Bloomfield, R; Civil, R; Coghill, DR; Dittmann, RW; Lecendreux, M; Otero, IH; Squires, LA; Zuddas, A | 1 |
| Buckley, NW; France, CP; Gosden, J; Hackett, D; Heal, DJ; Slater, N | 1 |
| Dirks, B; Gao, J; Kirsch, C; Knesevich, MA; Lasser, RA; Lindenmayer, JP; Nasrallah, H; Pucci, ML | 1 |
| Anderson, C; Banaschewski, T; Bloomfield, R; Civil, R; Coghill, DR; Higgins, N; Johnson, M; Lecendreux, M; Soutullo, C; Squires, LA; Zuddas, A | 1 |
| Adeyi, B; Banaschewski, T; Coghill, D; Hodgkins, P; Johnson, M; Lecendreux, M; Soutullo, C; Squires, LA; Zuddas, A | 1 |
| Cloutier, M; Erder, MH; Gauthier, G; Guérin, A; Hodgkins, P; Setyawan, J; Wu, E | 2 |
| Adler, LA; Dauphin, MR; Deas, PF; Dirks, B; Lasser, RA; Raychaudhuri, A; Weisler, RH | 1 |
| Adeyi, B; Babcock, T; Dirks, B; Findling, RL; Katic, A; Richards, C; Scheckner, B | 1 |
| Anderson, CS; Bloomfield, R; Caballero, B; Cardo, E; Civil, R; Coghill, D; Dittmann, RW; Higgins, N; Hodgkins, P; Lyne, A; Nagy, P | 1 |
| Almagor, D; Alsuwaidan, M; Bilkey, TS; Cha, DS; Gallaugher, LA; Kennedy, SH; McIntyre, RS; Powell, AM; Soczynska, JK; Szpindel, I; Woldeyohannes, HO | 1 |
| Cutler, AJ; Gao, J; Geibel, BB; Lasser, R; Patkar, AA; Richards, C; Sambunaris, A; Trivedi, MH | 1 |
| Adler, LA; Dauphin, M; Deas, P; Dirks, B; Raychaudhuri, A; Saylor, K; Weisler, R | 1 |
| Bradley-Johnson, S; Cook, A; Johnson, CM | 1 |
| Corcoran, M; Katic, A; Martin, PT; Zhang, P | 1 |
| Anderson, CS; Keefe, RS; Lasser, R; Madhoo, M; Roth, RM; Sambunaris, A; Trivedi, MH; Wu, J | 1 |
| Brammer, RJ; Gosden, J; Hackett, D; Heal, DJ; Kulkarni, RS; Rowley, HL | 1 |
| Geyer, H; Kwiatkowska, D; Schänzer, W; Sigmund, G; Thevis, M; Thomas, A; Vogel, M; Walpurgis, K | 1 |
| Hutson, PH; Pennick, M; Secker, R | 1 |
| Hodgkins, P; Roskell, NS; Setyawan, J; Zimovetz, EA | 1 |
| Caballero, B; Civil, R; Coghill, DR; Sorooshian, S | 1 |
| Alfonso, A; Augustus, JN; Babinski, DE; Bernstein, M; Crum, KI; Humphrey, HH; Pelham, WE; Slavec, J; Waschbusch, DA; Waxmonsky, JG | 1 |
| Anderson, CS; Banaschewski, T; Civil, R; Coghill, DR; Dauphin, M; Gasior, M; Higgins, N; Johnson, M; Lecendreux, M; Lyne, A; Squires, LA; Zuddas, A | 1 |
| Álvarez, FJ; Roncero, C | 1 |
| Cowan, RL; Guillamondegui, O; Prokop, JW; Tramontana, MG; Zald, D | 1 |
| Adeyi, B; Anderson, CS; Caballero, B; Cardo, E; Civil, R; Coghill, DR; Dittmann, RW; Hodgkins, P; Nagy, P | 1 |
| Adeyi, B; Banaschewski, T; Coghill, DR; Hodgkins, P; Johnson, M; Lecendreux, M; Squires, LA; Zuddas, A | 1 |
| Donnelly, P; Ferreira-Cornwell, MC; Freeman, J; Gao, J; Gasior, M; Roth, T; Zammit, G | 1 |
| Adler, LA; Alperin, S; Faraone, S; Leon, T | 1 |
| Adeyi, B; Babcock, T; Brams, M; Weisler, RH | 1 |
| Corcoran, M; Dirks, B; Ermer, J; Gertsik, L; Martin, P; Raychaudhuri, A; Stevenson, A; Walling, D | 1 |
| Maneeton, B; Maneeton, N; Martin, SD; Reungyos, J; Srisurapanont, M; Suttajit, S | 1 |
| Blom, TJ; Casuto, LS; Hawkins, JM; Keck, PE; Martens, BE; McElroy, SL; Mori, N | 1 |
| Alfonso, A; Augustus, JN; Babinski, DE; Bernstein, M; Crum, KI; Humphrey, H; Pelham, WE; Slavec, J; Waschbusch, DA; Waxmonsky, JG | 1 |
| Casey, JE; Duda, TA; McNevin, N | 1 |
| Erder, MH; Fridman, M | 1 |
| Ferreira-Cornwell, MC; Gao, J; Gasior, M; Hudson, JI; Jonas, J; McElroy, SL; Mitchell, JE; Wang, J; Whitaker, T; Wilfley, D | 1 |
| Banks, ML; Blough, BE; Hutsell, BA; Negus, SS; Poklis, JL | 1 |
| Locatelli, I; Munda, B; Stuhec, M; Svab, V | 1 |
| Kaland, ME; Klein-Schwartz, W | 1 |
| Folgering, JH; Heins, MS; Hutson, PH | 1 |
| Chen, LY; Crum, RM; Martins, SS; Mojtabai, R; Strain, EC | 1 |
| Barkla, XM; McArdle, PA; Newbury-Birch, D | 1 |
| Corcoran, M; Ermer, J; Lasseter, K; Marbury, T; Martin, PT; Yan, B | 1 |
| Bansal, R; Biezonski, D; Cha, J; Duan, Y; Gerum, S; Guilfoyle, DN; Hrabe, J; Kellendonk, C; Krivko, A; Leventhal, BL; Peterson, BS; Posner, J; Shah, R; Xie, S | 1 |
| Corcoran, M; Ermer, J; Lasseter, K; Martin, PT | 1 |
| Gao, J; He, S; Li, Y; Wang, Q; Zhang, Y | 1 |
| Adler, LA; Alperin, S; Faraone, SV; Leon, T | 1 |
| Helson, T; Keshen, A | 1 |
| Brammer, RJ; Goddard, S; Heal, DJ; Hutson, PH; Vickers, SP | 1 |
| Dolder, PC; Liechti, ME; Odermatt, A; Strajhar, P; Vizeli, P | 1 |
| Frampton, JE | 1 |
| Blanco-Silvente, L; Castells, X; Cunill, R | 1 |
| Dolder, PC; Kratschmar, DV; Liechti, ME; Odermatt, A; Patt, M; Strajhar, P; Vizeli, P | 1 |
| Adragna, M; Bufalo, B; Fabiano, GA; Gordon, CT; Hulme, KF; Janikowski, L; Lim, R; Rodriguez, Z; Sodano, SM; Stanford, S; Swiatek, D | 1 |
| Poulton, AS; Ross, L; Sapre, V; Stanislaus, C | 1 |
| Bennett, KE; Mac Avin, M; Teeling, M | 1 |
| Brink, P; Nielsen, J; Rohde, C; Østergaard, SD | 1 |
| Bai, Z; Charach, A; Chojecki, D; Eagles, C; Elliott, J; Hossain, A; Hsieh, SC; Husereau, D; Johnston, A; Kelly, SE; Mamdani, M; Skidmore, B; Tsakonas, E; Wells, GA | 1 |
| Sakai, C | 1 |
| Ahlner, J; Chermá, MD; Johansson, A; Jönsson, AK; Nilsson, GH | 1 |
| Davanian, AM; Fitzpatrick, JC; Groth, SL; Korducki, JP; Tran, DP | 1 |
| Avillach, P; Feroe, AG; Greenspun, P; Gutiérrez-Sacristán, A; Kohane, IS; Mousavi, S; Surati, R; Uppal, N | 1 |
| Crecraft, C; Mastrocco, A; Prittie, J | 1 |
| Chamberlain, SR; Dourish, CT; Higgs, S; Martin, E; Qureshi, KL; Rotshtein, P; Schneider, E; Spetter, MS | 1 |
| Andersen, CU; Andreasen, MF; Hasselstrøm, JB; Jornil, JR; Sørensen, LK | 1 |
| Iwase, H; Makino, Y; Namera, A; Noritake, K; Saka, K; Torimitsu, S; Yamaguchi, R | 1 |
| Brett, J; Bruno, C; Coghill, D; Gillies, MB; Havard, A; Pearson, SA; Zoega, H | 1 |
| Ahmed, T; Donnelly, GAE; Khattak, S; Parhar, A; Parhar, G; Ratz, J; Tourjman, V; van Stralen, J | 1 |
33 review(s) available for dextroamphetamine and lisdexamfetamine dimesylate
| Article | Year |
|---|---|
Lisdexamfetamine.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate | 2007 |
Pharmacologic treatment of ADHD: road conditions in driving patients to successful outcomes.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Trials as Topic; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Practice Patterns, Physicians'; Prodrugs; Propylamines; Treatment Outcome | 2008 |
Lisdexamfetamine dimesylate for childhood ADHD.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate | 2008 |
Lisdexamfetamine: a prodrug stimulant for ADHD.
Topics: Attention Deficit Disorder with Hyperactivity; Cross-Over Studies; Dextroamphetamine; Double-Blind Method; Drug Administration Schedule; Humans; Lisdexamfetamine Dimesylate; Nurse's Role; Placebos; Prodrugs; Psychiatric Nursing; Substance-Related Disorders; Treatment Outcome | 2008 |
The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Dextroamphetamine; Dose-Response Relationship, Drug; Humans; Lisdexamfetamine Dimesylate; Prodrugs; Substance-Related Disorders | 2009 |
Lisdexamfetamine for treatment of attention-deficit/hyperactivity disorder.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Randomized Controlled Trials as Topic; Sleep Initiation and Maintenance Disorders; Tachycardia | 2009 |
Lisdexamfetamine: a prodrug for the treatment of attention-deficit/hyperactivity disorder.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Interactions; Humans; Lisdexamfetamine Dimesylate; Prodrugs; Psychiatric Status Rating Scales | 2009 |
Lisdexamfetamine dimesylate: a prodrug stimulant for the treatment of ADHD in children and adults.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Prodrugs; Treatment Outcome | 2010 |
Duration of effect of oral long-acting stimulant medications for ADHD throughout the day.
Topics: Administration, Oral; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Trials as Topic; Dextroamphetamine; Drug Administration Schedule; Humans; Lisdexamfetamine Dimesylate; Time Factors | 2010 |
Understanding the effect size of lisdexamfetamine dimesylate for treating ADHD in children and adults.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Female; Humans; Lisdexamfetamine Dimesylate; Male; Treatment Outcome | 2012 |
Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate | 2010 |
Advances in the treatment of attention-deficit/hyperactivity disorder: a guide for pediatric neurologists.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Propylamines | 2010 |
[Stimulant and non-stimulant medication in current and future therapy for ADHD].
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Central Nervous System Stimulants; Child; Dextroamphetamine; Fatty Acids, Omega-3; Guanfacine; Histamine Agonists; Humans; Isoxazoles; Lisdexamfetamine Dimesylate; Memantine; Methylphenidate; Modafinil; Off-Label Use; Propylamines; Pyridines; Pyrrolidines; Receptors, AMPA | 2012 |
The use of lisdexamfetamine dimesylate for the treatment of ADHD.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate | 2012 |
[Diagnosis and treatment of attention deficit hyperactivity disorder in adults].
Topics: Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Automobile Driving; Behavior Therapy; Bupropion; Central Nervous System Stimulants; Combined Modality Therapy; Comorbidity; Dextroamphetamine; Diagnostic Self Evaluation; Educational Status; Female; Humans; Interpersonal Relations; Interview, Psychological; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Neuropsychological Tests; Occupations; Propylamines; Quality of Life; Severity of Illness Index; Symptom Assessment | 2012 |
Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Humans; Lisdexamfetamine Dimesylate; Randomized Controlled Trials as Topic; Treatment Outcome | 2012 |
Abuse-deterrent formulations, an evolving technology against the abuse and misuse of opioid analgesics.
Topics: Analgesics, Opioid; Buprenorphine; Chemistry, Pharmaceutical; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Morphine; Naltrexone; Opioid-Related Disorders; Pain; Prescription Drug Misuse; United States; United States Food and Drug Administration | 2012 |
An update on lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Middle Aged; Pediatrics; Practice Guidelines as Topic; Randomized Controlled Trials as Topic | 2013 |
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Body Size; Cardiovascular Diseases; Central Nervous System Stimulants; Child; Clonidine; Dextroamphetamine; Growth Disorders; Guanfacine; Heart Rate; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Propylamines; Psychoses, Substance-Induced; Seizures; Sleep Wake Disorders; Substance-Related Disorders; Suicide Prevention; Tic Disorders; Treatment Outcome | 2013 |
Toward quality care in ADHD: defining the goals of treatment.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Goals; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Propylamines; Quality of Health Care; Treatment Outcome | 2015 |
Amphetamine, past and present--a pharmacological and clinical perspective.
Topics: Adolescent; Adult; Amphetamine; Amphetamine-Related Disorders; Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Drug Design; Humans; Lisdexamfetamine Dimesylate; Narcolepsy; Prodrugs | 2013 |
Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Delayed-Action Preparations; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Medication Adherence; Prodrugs | 2013 |
Preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: a novel d-amphetamine pro-drug.
Topics: Animals; Brain; Central Nervous System Stimulants; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Prodrugs | 2014 |
Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Dopamine Uptake Inhibitors; Europe; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Models, Statistical; Propylamines; Treatment Outcome | 2014 |
A systematic review of the safety of lisdexamfetamine dimesylate.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Trials, Phase III as Topic; Dextroamphetamine; Dose-Response Relationship, Drug; Humans; Lisdexamfetamine Dimesylate; Prodrugs; Randomized Controlled Trials as Topic; Time Factors | 2014 |
The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders.
Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Mental Disorders | 2014 |
Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD.
Topics: Attention Deficit Disorder with Hyperactivity; Databases, Factual; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Placebos; Registries | 2014 |
Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Comparative Effectiveness Research; Dextroamphetamine; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Patient Acceptance of Health Care; Propylamines; Randomized Controlled Trials as Topic; Treatment Outcome | 2015 |
Are there any potentially dangerous pharmacological effects of combining ADHD medication with alcohol and drugs of abuse? A systematic review of the literature.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Alcohol Drinking; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Drug Interactions; Humans; Illicit Drugs; Lisdexamfetamine Dimesylate; Methylphenidate; Substance-Related Disorders | 2015 |
An Evaluation on the Efficacy and Safety of Treatments for Attention Deficit Hyperactivity Disorder in Children and Adolescents: a Comparison of Multiple Treatments.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dextroamphetamine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Treatment Outcome | 2017 |
Lisdexamfetamine Dimesylate: A Review in Paediatric ADHD.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Europe; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Quality of Life; Treatment Outcome | 2018 |
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
Topics: Adult; Amphetamines; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Randomized Controlled Trials as Topic | 2018 |
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bayes Theorem; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug-Related Side Effects and Adverse Reactions; Female; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Modafinil; Network Meta-Analysis; Quality of Life; Randomized Controlled Trials as Topic | 2020 |
84 trial(s) available for dextroamphetamine and lisdexamfetamine dimesylate
| Article | Year |
|---|---|
Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study.
Topics: Administration, Oral; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dextroamphetamine; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Lysine; Male; Treatment Outcome | 2007 |
Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Delayed-Action Preparations; Dextroamphetamine; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome | 2007 |
Multiple daily-dose pharmacokinetics of lisdexamfetamine dimesylate in healthy adult volunteers.
Topics: Adult; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Health; Human Experimentation; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Prodrugs | 2008 |
Relative bioavailability of lisdexamfetamine 70-mg capsules in fasted and fed healthy adult volunteers and in solution: a single-dose, crossover pharmacokinetic study.
Topics: Administration, Oral; Adult; Area Under Curve; Biological Availability; Blood Pressure; Capsules; Cross-Over Studies; Dextroamphetamine; Eating; Fasting; Female; Flushing; Food-Drug Interactions; Half-Life; Headache; Humans; Hyperkinesis; Lisdexamfetamine Dimesylate; Lysine; Male; Metabolic Clearance Rate; Molecular Structure; Tachycardia | 2008 |
Long-term effectiveness and safety of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder.
Topics: Administration, Oral; Appetite; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Headache; Humans; Lisdexamfetamine Dimesylate; Male; Psychiatric Status Rating Scales; Sleep Initiation and Maintenance Disorders; Time Factors; Treatment Outcome; Weight Loss | 2008 |
Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers.
Topics: Central Nervous System Stimulants; Dextroamphetamine; Double-Blind Method; Humans; Injections, Intravenous; Lisdexamfetamine Dimesylate; Male; Middle Aged; Prodrugs; Substance-Related Disorders | 2009 |
Effect of lisdexamfetamine dimesylate on parent-rated measures in children aged 6 to 12 years with attention-deficit/hyperactivity disorder: a secondary analysis.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Double-Blind Method; Female; Follow-Up Studies; Humans; Lisdexamfetamine Dimesylate; Male; Parents; Psychological Tests; Social Behavior; Treatment Outcome | 2008 |
Metabolism, distribution and elimination of lisdexamfetamine dimesylate: open-label, single-centre, phase I study in healthy adult volunteers.
Topics: Adult; Dextroamphetamine; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Tissue Distribution | 2008 |
Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Personality Assessment; Young Adult | 2008 |
Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse.
Topics: Administration, Oral; Adult; Blood Pressure; Central Nervous System Stimulants; Dextroamphetamine; Diethylpropion; Female; Heart Rate; Humans; Lisdexamfetamine Dimesylate; Male; Prodrugs; Substance-Related Disorders | 2009 |
Lisdexamfetamine in the treatment of attention-deficit/hyperactivity disorder in adults.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; Dextroamphetamine; Double-Blind Method; Dyspnea; Female; Headache; Humans; Irritable Mood; Lisdexamfetamine Dimesylate; Male; Middle Aged; Sleep Initiation and Maintenance Disorders; Tachycardia; Treatment Outcome; Young Adult | 2009 |
Effects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and extended-release mixed amphetamine salts in adults.
Topics: Adult; Amphetamine; Area Under Curve; Cross-Over Studies; Delayed-Action Preparations; Dextroamphetamine; Drug Administration Schedule; Female; Humans; Lisdexamfetamine Dimesylate; Male; Medication Therapy Management; Metabolic Clearance Rate; Middle Aged; Omeprazole; Proton Pump Inhibitors; Young Adult | 2009 |
Effectiveness, safety, and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: an open-label, dose-optimization study.
Topics: Appetite; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Dose-Response Relationship, Drug; Electrocardiography; Executive Function; Expressed Emotion; Female; Humans; Lisdexamfetamine Dimesylate; Male; Patient Satisfaction; Prodrugs; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Weight Loss | 2009 |
Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Lisdexamfetamine Dimesylate; Longitudinal Studies; Male; Middle Aged; Psychiatric Status Rating Scales; Severity of Illness Index; Time Factors; Vital Signs; Young Adult | 2009 |
Short-term effects of lisdexamfetamine dimesylate on cardiovascular parameters in a 4-week clinical trial in adults with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Cardiovascular System; Central Nervous System Stimulants; Dextroamphetamine; Electrocardiography; Female; Heart Rate; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Placebos; Prodrugs; Treatment Outcome | 2009 |
Lisdexamfetamine dimesylate: linear dose-proportionality, low intersubject and intrasubject variability, and safety in an open-label single-dose pharmacokinetic study in healthy adult volunteers.
Topics: Adult; Area Under Curve; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Electrocardiography; Female; Headache; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Prodrugs; Pulse; Young Adult | 2010 |
Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: a single-dose, randomized, open-label, crossover
Topics: Administration, Oral; Attention Deficit Disorder with Hyperactivity; Biotransformation; Central Nervous System Stimulants; Child; Cross-Over Studies; Dextroamphetamine; Dose-Response Relationship, Drug; Female; Humans; Lisdexamfetamine Dimesylate; Male; Prodrugs; Treatment Outcome | 2010 |
Effect of lisdexamfetamine dimesylate on sleep in children with ADHD.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Polysomnography; Sleep; Treatment Outcome | 2011 |
Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Cross-Over Studies; Dextroamphetamine; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotropic Drugs; Time Factors; Treatment Outcome; Work; Young Adult | 2010 |
Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cross-Over Studies; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Executive Function; Female; Humans; Lisdexamfetamine Dimesylate; Male | 2010 |
Does prior exposure to stimulants in children with ADHD impact cardiovascular parameters from lisdexamfetamine dimesylate?
Topics: Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; Child; Dextroamphetamine; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Lisdexamfetamine Dimesylate; Male; Single-Blind Method; Systole; Tachycardia | 2010 |
Clinically relevant changes in emotional expression in children with ADHD treated with lisdexamfetamine dimesylate.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Dose-Response Relationship, Drug; Emotions; Female; Humans; Lisdexamfetamine Dimesylate; Male; Psychiatric Status Rating Scales; Treatment Outcome | 2012 |
Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Dose-Response Relationship, Drug; Executive Function; Female; Humans; Lisdexamfetamine Dimesylate; Male; Neuropsychological Tests; Prospective Studies; Psychometrics | 2010 |
Prediction of placebo response in 2 clinical trials of lisdexamfetamine dimesylate for the treatment of ADHD.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Comorbidity; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Forecasting; Humans; Lisdexamfetamine Dimesylate; Middle Aged; Placebos; Severity of Illness Index; Treatment Outcome; Young Adult | 2011 |
Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lisdexamfetamine Dimesylate; Male; Personality Assessment; Psychometrics; Quality of Life; Treatment Outcome; United States | 2011 |
Long-term treatment outcomes with lisdexamfetamine dimesylate for adults with attention-deficit/hyperactivity disorder stratified by baseline severity.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Dextroamphetamine; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Young Adult | 2011 |
Effect size of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cross-Over Studies; Dextroamphetamine; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Neuropsychological Tests; Remission Induction; Severity of Illness Index; Treatment Outcome; Young Adult | 2011 |
The "younger-sibling-at-risk design": a pilot study of adolescents with ADHD and an older sibling with substance use disorder.
Topics: Adolescent; Adolescent Behavior; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Diagnosis, Dual (Psychiatry); Female; Humans; Lisdexamfetamine Dimesylate; Male; Medication Adherence; Pilot Projects; Research Design; Risk Factors; Siblings; Substance-Related Disorders | 2011 |
Dose response effects of lisdexamfetamine dimesylate treatment in adults with ADHD: an exploratory study.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Treatment Outcome | 2012 |
Intranasal versus oral administration of lisdexamfetamine dimesylate: a randomized, open-label, two-period, crossover, single-dose, single-centre pharmacokinetic study in healthy adult men.
Topics: Administration, Intranasal; Administration, Oral; Adolescent; Adult; Cross-Over Studies; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Reference Values; Young Adult | 2011 |
Effects of open-label lisdexamfetamine dimesylate on self-reported quality of life in adults with ADHD.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cross-Over Studies; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Quality of Life; Self Report; Workplace; Young Adult | 2011 |
Impact of stimulant pharmacotherapy on sleep quality: post hoc analyses of 2 large, double-blind, randomized, placebo-controlled trials.
Topics: Adult; Amphetamines; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Delayed-Action Preparations; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Sleep; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires | 2011 |
Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Double-Blind Method; Executive Function; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Psychiatric Status Rating Scales; ROC Curve; Young Adult | 2011 |
Pharmacokinetics of lisdexamfetamine dimesylate after targeted gastrointestinal release or oral administration in healthy adults.
Topics: Administration, Oral; Adolescent; Adult; Biotransformation; Central Nervous System Stimulants; Colon, Ascending; Cross-Over Studies; Dextroamphetamine; Drug Delivery Systems; Duodenum; Electronics, Medical; Gastrointestinal Transit; Half-Life; Humans; Ileum; Intestinal Absorption; Lisdexamfetamine Dimesylate; Male; Middle Aged; Prodrugs; Technology, Pharmaceutical; Young Adult | 2012 |
Double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in college students with ADHD.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cross-Over Studies; Dextroamphetamine; Double-Blind Method; Executive Function; Female; Humans; Learning; Lisdexamfetamine Dimesylate; Male; Neuropsychological Tests; Students; Treatment Outcome; Universities; Young Adult | 2012 |
Sex subgroup analysis of treatment response to lisdexamfetamine dimesylate in children aged 6 to 12 years with attention-deficit/hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Dose-Response Relationship, Drug; Female; Humans; Lisdexamfetamine Dimesylate; Male; Sex Factors | 2012 |
The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Automobile Driving; Central Nervous System Stimulants; Dextroamphetamine; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Psychomotor Performance; Treatment Outcome; User-Computer Interface; Young Adult | 2012 |
Adverse events in medication treatment-naïve children with attention-deficit/hyperactivity disorder: results from a small, controlled trial of lisdexamfetamine dimesylate.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Dose-Response Relationship, Drug; Female; Humans; Lisdexamfetamine Dimesylate; Male; Single-Blind Method | 2012 |
A pilot study of lis-dexamfetamine dimesylate (LDX/SPD489) to facilitate smoking cessation in nicotine-dependent adults with ADHD.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Pilot Projects; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2014 |
The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trial.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Emotions; Female; Humans; Lisdexamfetamine Dimesylate; Male; Mood Disorders; Parents; Personality Assessment; Treatment Outcome | 2014 |
Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Lisdexamfetamine Dimesylate; Long-Term Care; Male; Secondary Prevention; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2012 |
Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.
Topics: Adolescent; Adult; Analysis of Variance; Central Nervous System Stimulants; Cognition Disorders; Dextroamphetamine; Disability Evaluation; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Memory; Mental Processes; Middle Aged; Multiple Sclerosis; Neuropsychological Tests; Retrospective Studies; Statistics, Nonparametric; Young Adult | 2013 |
Use of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: a double blind, placebo-controlled study.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Cognition Disorders; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Executive Function; Fatigue Syndrome, Chronic; Female; Follow-Up Studies; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome; Young Adult | 2013 |
The effects of lisdexamfetamine dimesylate on driving behaviors in young adults with ADHD assessed with the Manchester driving behavior questionnaire.
Topics: Adolescent; Adult; Attention; Attention Deficit Disorder with Hyperactivity; Automobile Driving; Central Nervous System Stimulants; Computer Simulation; Dextroamphetamine; Female; Humans; Lisdexamfetamine Dimesylate; Male; Massachusetts; Psychomotor Performance; Surveys and Questionnaires; Young Adult | 2012 |
Phase synchronization of oxygenation waves in the frontal areas of children with attention-deficit hyperactivity disorder detected by optical diffusion spectroscopy correlates with medication.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cortical Synchronization; Dextroamphetamine; Female; Frontal Lobe; Humans; Lisdexamfetamine Dimesylate; Male; Oxygen; Oxygen Consumption; Spectroscopy, Near-Infrared; Statistics as Topic; Treatment Outcome | 2012 |
Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Data Interpretation, Statistical; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Substitution; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Psychiatric Status Rating Scales; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2012 |
European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adolescent Behavior; Appetite Regulation; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Behavior; Dextroamphetamine; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Europe; Female; Follow-Up Studies; Humans; Impulsive Behavior; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Patient Dropouts; Psychiatric Status Rating Scales; Severity of Illness Index | 2013 |
Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Lisdexamfetamine Dimesylate; Male; Psychiatric Status Rating Scales; Remission Induction; Treatment Outcome | 2013 |
ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Double-Blind Method; Drug Administration Schedule; Emotions; Female; Humans; Lisdexamfetamine Dimesylate; Male; Mood Disorders; Parents; Treatment Outcome | 2017 |
A long-term open-label safety and effectiveness trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adolescent Behavior; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Female; Humans; Lisdexamfetamine Dimesylate; Male; Psychiatric Status Rating Scales; Quality of Life | 2013 |
Parent-reported executive function behaviors and clinician ratings of attention-deficit/hyperactivity disorder symptoms in children treated with lisdexamfetamine dimesylate.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Behavior; Dextroamphetamine; Executive Function; Female; Humans; Lisdexamfetamine Dimesylate; Male; Parents; Psychiatric Status Rating Scales | 2013 |
An open-label investigation of the pharmacokinetic profiles of lisdexamfetamine dimesylate and venlafaxine extended-release, administered alone and in combination, in healthy adults.
Topics: Adolescent; Adult; Antidepressive Agents; Cross-Over Studies; Cyclohexanols; Dextroamphetamine; Drug Therapy, Combination; Female; Humans; Lisdexamfetamine Dimesylate; Male; Reference Values; Venlafaxine Hydrochloride; Young Adult | 2013 |
Pharmacokinetics of coadministered guanfacine extended release and lisdexamfetamine dimesylate.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Central Nervous System Stimulants; Dextroamphetamine; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Female; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Therapeutic Equivalency; Vital Signs | 2013 |
Efficacy and safety of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder and recent methylphenidate use.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Dextroamphetamine; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Prodrugs; Treatment Outcome | 2013 |
Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Parents; Prodrugs; Treatment Outcome | 2014 |
Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phases.
Topics: Adult; Antipsychotic Agents; Dextroamphetamine; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lisdexamfetamine Dimesylate; Male; Outpatients; Schizophrenia | 2013 |
A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate | 2013 |
Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Double-Blind Method; Drug Administration Schedule; Educational Status; Female; Humans; Lisdexamfetamine Dimesylate; Male; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2013 |
Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study.
Topics: Adult; Attention; Attention Deficit Disorder with Hyperactivity; Behavioral Symptoms; Central Nervous System Stimulants; Dextroamphetamine; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Drug Monitoring; Executive Function; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Self-Assessment; Treatment Outcome | 2013 |
Treatment outcomes with lisdexamfetamine dimesylate in children who have attention-deficit/hyperactivity disorder with emotional control impairments.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Emotions; Executive Function; Female; Humans; Lisdexamfetamine Dimesylate; Male; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 2013 |
Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Child; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Propylamines; Treatment Outcome | 2013 |
The effect of lisdexamfetamine dimesylate on body weight, metabolic parameters, and attention deficit hyperactivity disorder symptomatology in adults with bipolar I/II disorder.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Body Weight; Dextroamphetamine; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Treatment Outcome; Young Adult | 2013 |
A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Central Nervous System Stimulants; Citalopram; Depressive Disorder, Major; Dextroamphetamine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Personality Inventory; Psychometrics; Young Adult | 2013 |
Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study.
Topics: Activities of Daily Living; Adult; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Executive Function; Female; Humans; Lisdexamfetamine Dimesylate; Male; Neuropsychological Tests; Quality of Life; Self Report; Treatment Outcome | 2013 |
Randomized, double-blind, placebo-controlled, crossover study of the effects of lisdexamfetamine dimesylate and mixed amphetamine salts on cognition throughout the day in adults with attention-deficit/hyperactivity disorder.
Topics: Adult; Amphetamines; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cognition; Cross-Over Studies; Dextroamphetamine; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Neuropsychological Tests; Pilot Projects; Psychometrics; Reaction Time; Sensitivity and Specificity; Time Factors; Treatment Outcome; Young Adult | 2014 |
Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder.
Topics: Adult; Antidepressive Agents; Cognition Disorders; Depressive Disorder, Major; Dextroamphetamine; Double-Blind Method; Drug Therapy, Combination; Executive Function; Female; Humans; Lisdexamfetamine Dimesylate; Male; Psychiatric Status Rating Scales; Psychotropic Drugs; Remission Induction; Single-Blind Method; Treatment Outcome | 2014 |
Does pharmacological treatment of ADHD in adults enhance parenting performance? Results of a double-blind randomized trial.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Parent-Child Relations; Parenting; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 2014 |
Participant-perceived quality of life in a long-term, open-label trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Lisdexamfetamine Dimesylate; Psychiatric Status Rating Scales; Quality of Life; Treatment Outcome | 2014 |
Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Treatment Failure; Treatment Outcome; Withholding Treatment | 2014 |
Traumatic brain injury-related attention deficits: treatment outcomes with lisdexamfetamine dimesylate (Vyvanse).
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Brain Injuries; Central Nervous System Stimulants; Cross-Over Studies; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Executive Function; Female; Humans; Lisdexamfetamine Dimesylate; Male; Neuropsychological Tests; Treatment Outcome | 2014 |
Treatment response and remission in a double-blind, randomized, head-to-head study of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit hyperactivity disorder.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Double-Blind Method; Drug Administration Schedule; Humans; Lisdexamfetamine Dimesylate; Propylamines; Remission Induction; Severity of Illness Index; Treatment Outcome | 2014 |
Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Double-Blind Method; Europe; Female; Humans; Lisdexamfetamine Dimesylate; Male; Psychiatric Status Rating Scales; Psychotropic Drugs; Quality of Life; Treatment Outcome | 2014 |
Maintenance of wakefulness with lisdexamfetamine dimesylate, compared with placebo and armodafinil in healthy adult males undergoing acute sleep loss.
Topics: Administration, Oral; Adult; Benzhydryl Compounds; Dextroamphetamine; Double-Blind Method; Health Status; Humans; Lisdexamfetamine Dimesylate; Male; Modafinil; Sleep Deprivation; Time Factors; Wakefulness; Wakefulness-Promoting Agents; Young Adult | 2014 |
Relationship of ADHD symptoms and global illness severity in adults treated with lisdexamfetamine dimesylate.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Recurrence; Severity of Illness Index; Young Adult | 2014 |
Safety and pharmacokinetics of lisdexamfetamine dimesylate in adults with clinically stable schizophrenia: a randomized, double-blind, placebo-controlled trial of ascending multiple doses.
Topics: Adult; Cross-Over Studies; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Schizophrenia | 2014 |
Adjunctive lisdexamfetamine in bipolar depression: a preliminary randomized, placebo-controlled trial.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Central Nervous System Stimulants; Dextroamphetamine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Ohio; Prospective Studies; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome | 2015 |
Interpreting the results of a retrospective comparison of test and reference treatments in a randomized clinical trial setting.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bayes Theorem; Child; Dextroamphetamine; Double-Blind Method; Humans; Lisdexamfetamine Dimesylate; Retrospective Studies | 2015 |
Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial.
Topics: Adult; Binge-Eating Disorder; Dextroamphetamine; Dopamine Uptake Inhibitors; Double-Blind Method; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Severity of Illness Index; Treatment Outcome | 2015 |
Relative Bioavailabilities of Lisdexamfetamine Dimesylate and D-Amphetamine in Healthy Adults in an Open-Label, Randomized, Crossover Study After Mixing Lisdexamfetamine Dimesylate With Food or Drink.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Biological Availability; Capsules; Carbonated Beverages; Cross-Over Studies; Dextroamphetamine; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Prodrugs; Therapeutic Equivalency; Young Adult | 2016 |
Pharmacokinetic and Pharmacodynamic Properties of Lisdexamfetamine in Adults with Attention-Deficit/Hyperactivity Disorder.
Topics: Adult; Area Under Curve; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Prodrugs; Psychiatric Status Rating Scales; Single-Blind Method; Time Factors; Treatment Outcome; Young Adult | 2017 |
Acute effects of lisdexamfetamine and D-amphetamine on social cognition and cognitive performance in a placebo-controlled study in healthy subjects.
Topics: Adult; Central Nervous System Stimulants; Cognition; Cross-Over Studies; Dextroamphetamine; Double-Blind Method; Emotions; Female; Healthy Volunteers; Humans; Lisdexamfetamine Dimesylate; Male; Neuropsychological Tests; Sexual Behavior; Social Behavior; Young Adult | 2018 |
Effects of lisdexamfetamine on plasma steroid concentrations compared with d-amphetamine in healthy subjects: A randomized, double-blind, placebo-controlled study.
Topics: Adrenocorticotropic Hormone; Adult; Central Nervous System Stimulants; Cross-Over Studies; Dextroamphetamine; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Placebo Effect; Steroids; Young Adult | 2019 |
Efficacy of lisdexamfetamine dimesylate for promoting occupational success in adolescents and young adults with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Lisdexamfetamine Dimesylate; Treatment Outcome; Young Adult | 2021 |
The effects of lisdexamfetamine dimesylate on eating behaviour and homeostatic, reward and cognitive processes in women with binge-eating symptoms: an experimental medicine study.
Topics: Attention Deficit Disorder with Hyperactivity; Binge-Eating Disorder; Biomedical Research; Central Nervous System Stimulants; Cognition; Dextroamphetamine; Double-Blind Method; Feeding Behavior; Female; Humans; Lisdexamfetamine Dimesylate; Reward; Treatment Outcome | 2022 |
57 other study(ies) available for dextroamphetamine and lisdexamfetamine dimesylate
| Article | Year |
|---|---|
An evaluation of the cytochrome p450 inhibition potential of lisdexamfetamine in human liver microsomes.
Topics: Attention Deficit Disorder with Hyperactivity; Cytochrome P-450 Enzyme System; Dextroamphetamine; Drug Interactions; Humans; Lisdexamfetamine Dimesylate; Microsomes, Liver; NADP | 2007 |
Molecule of the month: lisdexamfetamine mesilate.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Behavior; Dextroamphetamine; Drug Labeling; Humans; Lisdexamfetamine Dimesylate; Treatment Outcome | 2007 |
Lisdexamfetamine dimesylate.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Dopamine; Drug Approval; Humans; Lisdexamfetamine Dimesylate; Norepinephrine; Prodrugs; Randomized Controlled Trials as Topic; Substance-Related Disorders; United States; United States Food and Drug Administration | 2007 |
Lisdexamfetamine dimesylate (Vyvanse) for ADHD.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Drug Interactions; Humans; Lisdexamfetamine Dimesylate | 2007 |
Toxicity profile of lisdexamfetamine dimesylate in three independent rat toxicology studies.
Topics: Administration, Oral; Animals; Blood Chemical Analysis; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Lethal Dose 50; Lisdexamfetamine Dimesylate; Male; Organ Size; Prodrugs; Rats; Rats, Sprague-Dawley; Self Mutilation; Toxicity Tests, Acute; Toxicity Tests, Chronic | 2007 |
The effect of stimulant treatment for ADHD on later substance abuse and the potential for medication misuse, abuse, and diversion.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Delayed-Action Preparations; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Psychotropic Drugs; Risk Factors; Substance-Related Disorders; Time Factors | 2007 |
Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Child; Delayed-Action Preparations; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Prodrugs; Randomized Controlled Trials as Topic; Treatment Outcome | 2008 |
Poison centers detect an unexpectedly frequent number of adverse drug reactions to lisdexamfetamine.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Poison Control Centers; Retrospective Studies; United States; United States Food and Drug Administration | 2008 |
Lisdexamfetamine dimesylate: in attention-deficit hyperactivity disorder in adults.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clinical Trials, Phase III as Topic; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Lisdexamfetamine Dimesylate; Male; Surveys and Questionnaires; Young Adult | 2009 |
Case histories in pharmaceutical risk management.
Topics: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Dextroamphetamine; Drug and Narcotic Control; Drug Industry; History, 20th Century; History, 21st Century; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Naloxone; Oxycodone; Product Surveillance, Postmarketing; Risk Management; Sodium Oxybate; Substance-Related Disorders | 2009 |
Attention-deficit/hyperactivity disorder: the road traveled and the road ahead.
Topics: Amphetamine-Related Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate | 2009 |
Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy.
Topics: Administration, Oral; Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dexmethylphenidate Hydrochloride; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Drug Therapy, Combination; Half-Life; Health Care Costs; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Pediatrics; Prodrugs; Propylamines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Effects of lisdexamfetamine dimesylate treatment for ADHD on growth.
Topics: Attention Deficit Disorder with Hyperactivity; Body Height; Body Mass Index; Body Weight; Central Nervous System Stimulants; Child; Clinical Trials, Phase III as Topic; Cross-Over Studies; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Lisdexamfetamine Dimesylate; Male; Randomized Controlled Trials as Topic | 2010 |
Assessing effects of treatment with lisdexamfetamine dimesylate for pediatric ADHD using a parental survey.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Female; Health Surveys; Humans; Lisdexamfetamine Dimesylate; Male; Outcome Assessment, Health Care; Parents; Pediatrics; Severity of Illness Index; Surveys and Questionnaires | 2010 |
Eosinophilic hepatitis in an adolescent during lisdexamfetamine dimesylate treatment for ADHD.
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Attention Deficit Disorder with Hyperactivity; Chemical and Drug Induced Liver Injury; Dextroamphetamine; Eosinophilia; Humans; Lisdexamfetamine Dimesylate; Male | 2010 |
Newly approved once-daily formulations of medications for the treatment of Attention Deficit (Hyperactivity) Disorder (ADHD) in children and adolescents.
Topics: Administration, Cutaneous; Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dextroamphetamine; Drug Administration Schedule; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Locus Coeruleus; Methylphenidate; Neurons; Nutrition Surveys; Prefrontal Cortex; Propylamines | 2010 |
Reading performance as a function of treatment with lisdexamfetamine dimesylate in elementary school children diagnosed with ADHD.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Female; Humans; Lisdexamfetamine Dimesylate; Male; Reading; Single-Blind Method; Treatment Outcome | 2012 |
The use of dopaminergic and stimulant drugs for the treatment of depression.
Topics: Amphetamines; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Depressive Disorder, Major; Dextroamphetamine; Dopamine; Dopamine Agents; Drug Therapy, Combination; Epinephrine; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Modafinil; Norepinephrine; Propylamines | 2012 |
Identifying patient subgroups who benefit most from a treatment: using administrative claims data to uncover treatment heterogeneity.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Comparative Effectiveness Research; Costs and Cost Analysis; Dextroamphetamine; Female; Health Services; Humans; Insurance Claim Review; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Models, Statistical | 2012 |
A cardiopulmonary study of lisdexamfetamine in adults with attention-deficit/hyperactivity disorder.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Central Nervous System Stimulants; Dextroamphetamine; Echocardiography; Exercise Test; Female; Heart; Heart Rate; Humans; Hypertension; Lisdexamfetamine Dimesylate; Male; Middle Aged; Prospective Studies | 2013 |
Lisdexamfetamine and immediate release d-amfetamine - differences in pharmacokinetic/pharmacodynamic relationships revealed by striatal microdialysis in freely-moving rats with simultaneous determination of plasma drug concentrations and locomotor activit
Topics: Animals; Area Under Curve; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Dextroamphetamine; Dopamine; Dose-Response Relationship, Drug; Indicators and Reagents; Injections, Intraperitoneal; Lisdexamfetamine Dimesylate; Male; Microdialysis; Motor Activity; Neostriatum; Rats; Rats, Sprague-Dawley | 2012 |
[The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents].
Topics: Adolescent; Adult; Amphetamines; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Child; Controlled Clinical Trials as Topic; Dextroamphetamine; Half-Life; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Risk Factors; Substance-Related Disorders | 2012 |
Possible association with amphetamine usage and development of high altitude pulmonary edema.
Topics: Altitude Sickness; Amphetamine; Attention Deficit Disorder with Hyperactivity; Dextroamphetamine; Humans; Hypertension, Pulmonary; Lisdexamfetamine Dimesylate; Male; Middle Aged | 2012 |
Dexmedetomidine to treat lisdexamfetamine overdose and serotonin toxidrome in a 6-year-old girl.
Topics: Adrenergic alpha-2 Receptor Agonists; Anti-Anxiety Agents; Central Nervous System Stimulants; Child; Dexmedetomidine; Dextroamphetamine; Drug Overdose; Female; Humans; Lisdexamfetamine Dimesylate; Lorazepam; Midazolam; Serotonin Syndrome | 2012 |
Effects of lithium on oxidative stress and behavioral alterations induced by lisdexamfetamine dimesylate: relevance as an animal model of mania.
Topics: Animals; Antimanic Agents; Behavior, Animal; Bipolar Disorder; Brain Chemistry; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Glutathione; Hippocampus; Lipid Peroxidation; Lisdexamfetamine Dimesylate; Lithium; Lithium Carbonate; Male; Motor Activity; Neostriatum; Oxidative Stress; Prefrontal Cortex; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2013 |
Chronic fatigue syndrome: 3 cases and a discussion of the natural history of attention-deficit/hyperactivity disorder.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Fatigue Syndrome, Chronic; Female; Fibromyalgia; Humans; Lisdexamfetamine Dimesylate; Middle Aged; Treatment Outcome | 2013 |
Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis.
Topics: Adolescent; Adult; Age Distribution; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Family Health; Female; Humans; Insurance Claim Review; Lisdexamfetamine Dimesylate; Longitudinal Studies; Male; Medication Adherence; Retrospective Studies; Sex Distribution; United States | 2013 |
A preclinical evaluation of the discriminative and reinforcing properties of lisdexamfetamine in comparison to D-amfetamine, methylphenidate and modafinil.
Topics: Animals; Benzhydryl Compounds; Cocaine; Dextroamphetamine; Discrimination, Psychological; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Lisdexamfetamine Dimesylate; Methylphenidate; Modafinil; Rats; Reinforcement, Psychology; Self Administration | 2013 |
Comparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and adults.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Insurance Claim Review; Lisdexamfetamine Dimesylate; Male; Retrospective Studies; United States; Young Adult | 2013 |
Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications.
Topics: Adolescent; Adult; Age Factors; Amphetamines; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Comorbidity; Dextroamphetamine; Drug Combinations; Female; Humans; Insurance Claim Review; Lisdexamfetamine Dimesylate; Male; Medication Adherence; Retrospective Studies; United States; Young Adult | 2013 |
What place for lisdexamfetamine in children and adolescents with ADHD?
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Practice Guidelines as Topic; Severity of Illness Index; United Kingdom | 2013 |
Effects of white noise on off-task behavior and academic responding for children with ADHD.
Topics: Achievement; Acoustic Stimulation; Amphetamines; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Female; Humans; Learning; Lisdexamfetamine Dimesylate; Male; Noise | 2014 |
Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats.
Topics: Animals; Behavior, Animal; Benzhydryl Compounds; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Microdialysis; Modafinil; Motor Activity; Prefrontal Cortex; Rats; Rats, Sprague-Dawley | 2014 |
Isotope-dilution mass spectrometric quantification of the prodrug lisdexamfetamine in human urine in doping control analysis.
Topics: Dextroamphetamine; Doping in Sports; Female; Humans; Limit of Detection; Linear Models; Lisdexamfetamine Dimesylate; Male; Mass Spectrometry; Prodrugs; Reproducibility of Results | 2014 |
Clinical effects of lisdexamfetamine and mixed amphetamine salts immediate release in adult ADHD: results of a crossover design clinical trial.
Topics: Adult; Amphetamines; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cross-Over Studies; Delayed-Action Preparations; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Executive Function; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Salts; Single-Blind Method; Young Adult | 2014 |
A pilot study of stimulant medication for adults with attention-deficit/hyperactivity disorder (ADHD) who are parents of adolescents with ADHD: the acute effects of stimulant medication on observed parent-adolescent interactions.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Parent-Child Relations; Parenting; Pilot Projects | 2014 |
Variability of kinematic graphomotor fluency in adults with ADHD.
Topics: Adolescent; Adult; Amphetamines; Attention Deficit Disorder with Hyperactivity; Automation; Biomechanical Phenomena; Case-Control Studies; Central Nervous System Stimulants; Dextroamphetamine; Female; Handwriting; Humans; Intelligence Tests; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Middle Aged; Motor Skills; Reproducibility of Results; Young Adult | 2014 |
Preclinical Assessment of Lisdexamfetamine as an Agonist Medication Candidate for Cocaine Addiction: Effects in Rhesus Monkeys Trained to Discriminate Cocaine or to Self-Administer Cocaine in a Cocaine Versus Food Choice Procedure.
Topics: Animals; Choice Behavior; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Dextroamphetamine; Discrimination, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Food Preferences; Lisdexamfetamine Dimesylate; Macaca mulatta; Male; Self Administration; Time Factors | 2015 |
Comparison of lisdexamfetamine and dextroamphetamine exposures reported to U.S. poison centers.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Chi-Square Distribution; Child; Delayed-Action Preparations; Dextroamphetamine; Drug Overdose; Humans; Linear Models; Lisdexamfetamine Dimesylate; Medication Errors; Odds Ratio; Poison Control Centers; Poisoning; Retrospective Studies; Risk Factors; Suicide, Attempted; United States; Young Adult | 2015 |
Effects of lisdexamfetamine alone and in combination with s-citalopram on acetylcholine and histamine efflux in the rat pre-frontal cortex and ventral hippocampus.
Topics: Acetylcholine; Animals; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Citalopram; Dextroamphetamine; Drug Therapy, Combination; Hippocampus; Histamine Release; Lisdexamfetamine Dimesylate; Male; Microdialysis; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2015 |
Patterns of concurrent substance use among adolescent nonmedical ADHD stimulant users.
Topics: Adolescent; Amphetamines; Analgesics, Opioid; Central Nervous System Stimulants; Child; Cocaine-Related Disorders; Dextroamphetamine; Female; Hallucinogens; Heroin Dependence; Humans; Hypnotics and Sedatives; Inhalant Abuse; Lisdexamfetamine Dimesylate; Male; Marijuana Smoking; Methylphenidate; Multivariate Analysis; Pemoline; Prescription Drug Misuse; Regression Analysis; Substance-Related Disorders; Underage Drinking; United States | 2015 |
A Single-Dose, Open-Label Study of the Pharmacokinetics, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Individuals With Normal and Impaired Renal Function.
Topics: Adult; Aged; Area Under Curve; Dextroamphetamine; Female; Glomerular Filtration Rate; Humans; Kidney; Lisdexamfetamine Dimesylate; Male; Middle Aged; Renal Dialysis; Renal Insufficiency | 2016 |
Longitudinal magnetic resonance imaging reveals striatal hypertrophy in a rat model of long-term stimulant treatment.
Topics: Animals; Body Weight; Central Nervous System Stimulants; Dextroamphetamine; Hypertrophy; Lisdexamfetamine Dimesylate; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neostriatum; Organ Size; Rats; Rats, Sprague-Dawley | 2016 |
Preliminary Evidence for the Off-Label Treatment of Bulimia Nervosa With Psychostimulants: Six Case Reports.
Topics: Adult; Amphetamine; Bulimia Nervosa; Delayed-Action Preparations; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Retrospective Studies; Young Adult | 2017 |
Investigation of impulsivity in binge-eating rats in a delay-discounting task and its prevention by the d-amphetamine prodrug, lisdexamfetamine.
Topics: Animals; Bulimia; Choice Behavior; Conditioning, Operant; Dextroamphetamine; Female; Food; Impulsive Behavior; Lisdexamfetamine Dimesylate; Male; Prodrugs; Rats; Rats, Wistar; Reward | 2017 |
Dose Adjustment of Stimulants for Children with Attention-Deficit/Hyperactivity Disorder: A Retrospective Chart Review of the Impact of Exceeding Recommended Doses.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Dose-Response Relationship, Drug; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Retrospective Studies; Time Factors | 2020 |
Trends in attention-deficit and hyperactivity disorder (ADHD) medications among children and young adults in Ireland: a repeated cross-sectional study from 2005 to 2015.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Cross-Sectional Studies; Dextroamphetamine; Female; Humans; Hypnotics and Sedatives; Infant; Infant, Newborn; Ireland; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Practice Patterns, Physicians'; Young Adult | 2020 |
The use of stimulants in depression: Results from a self-controlled register study.
Topics: Adult; Amphetamine; Central Nervous System Stimulants; Denmark; Depression; Dextroamphetamine; Drug Prescriptions; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Modafinil; Registries; Suicide, Attempted | 2020 |
[Pharmacological properties and clinical effects of the ADHD drug, Lisdexamfetamine (Vyvanse
Topics: Attention Deficit Disorder with Hyperactivity; Capsules; Child; Dextroamphetamine; Humans; Japan; Lisdexamfetamine Dimesylate | 2020 |
Use of Lisdexamfetamine or Amphetamine? Interpretation of Chiral Amphetamine Analyses.
Topics: Amphetamine; Central Nervous System Stimulants; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Sweden | 2022 |
Bilateral Acute Angle Closure in a Pediatric Patient Taking Lisdexamfetamine Dimesylate (Vyvanse).
Topics: Adolescent; Central Nervous System Stimulants; Child; Dextroamphetamine; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lisdexamfetamine Dimesylate; Male; Treatment Outcome | 2021 |
Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database.
Topics: Adolescent; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Bupropion; Child; Child, Preschool; Cohort Studies; Comorbidity; Data Mining; Depressive Disorder, Major; Dexmethylphenidate Hydrochloride; Dextroamphetamine; Female; Health Services Accessibility; Humans; Insurance; Lisdexamfetamine Dimesylate; Male; Managed Care Programs; Prevalence; Retrospective Studies | 2021 |
Hypoglycemia and presumptive rhabdomyolysis secondary to lisdexamfetamine toxicosis in 3 cats.
Topics: Animals; Cat Diseases; Cats; Dextroamphetamine; Hypoglycemia; Lisdexamfetamine Dimesylate; Rhabdomyolysis | 2022 |
Stability of Lisdexamfetamine in Sampled Whole Blood-Implications of Sampling Tube Additives and Storage Temperature for Interpretation of Impairment.
Topics: Central Nervous System Stimulants; Dextroamphetamine; Double-Blind Method; Fluorides; Lisdexamfetamine Dimesylate; Temperature; Treatment Outcome | 2023 |
Detection of lisdexamfetamine and its metabolite d-amphetamine in urine and gastric contents collected from a cadaver at forensic autopsy.
Topics: Amphetamine; Autopsy; Cadaver; Chromatography, Liquid; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Prodrugs; Tandem Mass Spectrometry | 2023 |
Expanded access to publicly subsidised lisdexamfetamine treatment for adults with attention-deficit/hyperactivity disorder: An interrupted time-series analysis.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Lisdexamfetamine Dimesylate; Treatment Outcome | 2023 |
Real-World Efficacy and Safety of Extended-Release Methylphenidate (PRC-063) in the Treatment of ADHD in Pediatric and Adult Subjects: Results of a Phase IV Multicenter Comparison With Lisdexamfetamine Dimesylate.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Quality of Life; Treatment Outcome | 2023 |